Therefore, the regulation of theeffect of IL4I1 on the immune system and injured myocardium might offer a newdirection for limiting MI size, preventing adverse left ventricular remodeling,and improving clinical outcomes following MI. This evidence concerns the gene IL4I1 and myocardial infarction.